AstraZeneca drags Dr Reddy's Labs to court on patent, says report
Updated : July 25, 2018 12:55 PM IST
AstraZeneca filed a lawsuit in the Delhi High Court against the pharmaceutical major Dr Reddy’s Laboratories to block the company from launching the generic versions of Brilinta.
The court asked Dr Reddy’s on Tuesday to file a reply to the lawsuit and will hear its arguments on July 31.
One of AstraZeneca’s key patents for Brilinta expired in India this month, it has triggered the launch opportunities for local drug makers.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more